tDCS + Cognitive Training for Stroke
Trial Summary
What is the purpose of this trial?
Specific Aim 1: Complete pilot testing of study protocol in individuals with chronic stroke for feasibility evaluation and protocol refinement. Specific Aim 2: Estimate the preliminary effect of CO-OP+tDCS on activity performance in individuals with chronic stroke.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment tDCS + Cognitive Training for Stroke?
Research shows that combining transcranial direct current stimulation (tDCS) with other therapies, like motor imagery and functional training, can improve upper limb function in stroke patients. Additionally, tDCS has been found to enhance the effects of standard physiotherapy and improve activities of daily living and cognitive functioning in stroke survivors.12345
Is transcranial direct current stimulation (tDCS) safe for humans?
How does the tDCS + Cognitive Training treatment for stroke differ from other treatments?
The tDCS + Cognitive Training treatment is unique because it combines non-invasive brain stimulation (tDCS) with cognitive strategy training to improve daily life task performance in stroke patients. This approach is novel as it targets both brain activity and cognitive skills, which is different from traditional physical rehabilitation methods.1112131415
Research Team
Anna E Boone, PhD, OTR/L
Principal Investigator
University of Missouri Occupational Therapy
Eligibility Criteria
This trial is for individuals who had an ischemic stroke at least 6 months ago, are not currently in therapy, and have at least four personal goals they want to achieve. People with severe depression, dementia symptoms, other neurological disorders, moderate to severe speech difficulties (aphasia), or any condition that makes tDCS unsafe cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either CO-OP with tDCS, computer cognitive training with tDCS, CO-OP with sham tDCS, or computer cognitive training with sham tDCS. Each session includes 20 minutes of tDCS or sham followed by 45 minutes of the assigned intervention.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 1-month post-intervention.
Treatment Details
Interventions
- Computer Cognitive Training Procedures
- CO-OP Procedures
- sham tDCS group
- tDCS
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor